.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Queensland Health
Merck
Healthtrust
Fish and Richardson
Fuji
Cipla
Moodys
Chubb
Farmers Insurance

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019976

« Back to Dashboard

NDA 019976 describes PHOSLO, which is a drug marketed by Fresenius Medcl and is included in two NDAs. It is available from six suppliers. There are two patents protecting this drug and one Paragraph IV challenge. Additional details are available on the PHOSLO profile page.

The generic ingredient in PHOSLO is calcium acetate. There are two hundred and seventy drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the calcium acetate profile page.

Summary for 019976

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Genitourinary Agents
Therapeutic Nutrients/Minerals/Electrolytes
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength667MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Dec 10, 1990TE:RLD:Yes

Expired Orange Book Patents for NDA: 019976

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Fresenius MedclPHOSLOcalcium acetateTABLET;ORAL019976-001Dec 10, 1990► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
McKinsey
Julphar
Dow
US Army
UBS
QuintilesIMS
Colorcon
Federal Trade Commission
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot